Webinar

Swiss Breakfast – Q3 2026

Global Pharma, Global Reinsurance and the Future of Switzerland's Too-Big-To-Fail Framework

Join Moody's Ratings analysts for a focused discussion on key credit developments shaping the outlook for global pharmaceutical and reinsurance companies, alongside an update on Switzerland's evolving too-big-to-fail regulatory framework. Through a series of analyst-led presentations and Q&A sessions, attendees will hear perspectives on sector trends, regulatory developments and the factors influencing credit conditions across these important markets.

Key topics will include:

  • Global pharma outlook: Key credit considerations and industry developments influencing pharmaceutical companies.
  • Global reinsurance outlook: Credit trends and market dynamics affecting the reinsurance sector.
  • Switzerland's too-big-to-fail framework: An update on regulatory developments and their implications for the Swiss banking landscape.
  • Analyst Q&A: Opportunity to hear further perspectives on outlooks, trends and regulatory developments.
If you have any questions, please contact esther.aldwinckle1@moodys.com.

Speakers

Edoardo Calandro

Edoardo Calandro

Senior Vice President, Financial Institutions

Moody's Ratings

Benjamin Serra

Benjamin Serra

Senior Vice President, Financial Institutions

Moody's Ratings

Christian Badorff

Christian Badorff

Vice President, Financial Institutions

Moody's Ratings

Francesco Bozzano

Francesco Bozzano

Vice President, Corporate Finance

Moody's Ratings

Tobias Wagner

Tobias Wagner

Executive Director, Corporate Finance Group

Moody’s Ratings

JS

Jonathan Stalmann

Assistant Vice President

Moody's Ratings

Join us online for Swiss Breakfast – Q3 2026